{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:47:49Z","timestamp":1782712069345,"version":"3.54.5"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Epidemiol."],"abstract":"<jats:p>Tuberculosis (TB) remains a major global public health challenge and one of the leading infectious causes of mortality worldwide, with India contributing approximately 26% of the global TB burden. Despite substantial progress under the National Tuberculosis Elimination Programme (NTEP), India's efforts to achieve the ambitious 2025 TB elimination target continue to face major challenges due to the COVID-19 pandemic, multidrug-resistant tuberculosis (MDR-TB), healthcare disparities, and limitations in surveillance and reporting systems. This review provides a comprehensive overview of the epidemiology of TB in India and critically evaluates the impact of COVID-19, drug resistance, healthcare accessibility, and emerging diagnostic technologies on TB control efforts. A structured literature search was conducted using PubMed, Scopus, and Google Scholar, along with reports from the World Health Organization and the Government of India. The reviewed evidence indicates that the COVID-19 pandemic significantly disrupted TB diagnosis, treatment, surveillance, and healthcare accessibility, leading to declines in case notification and the possible accumulation of undiagnosed TB cases. In addition, the increasing burden of MDR\/RR-TB, fragmented private healthcare systems, underreporting, and unequal access to diagnostics and treatment continue to hinder progress toward TB elimination. Although advancements including molecular diagnostics, digital surveillance platforms such as Nikshay, AI-assisted screening, and patient-support programmes have strengthened TB control strategies, important challenges related to implementation, infrastructure, scalability, and antimicrobial stewardship remain unresolved. This review highlights the need for integrated and patient-centred TB control strategies that combine rapid diagnostics, strengthened surveillance, public\u2013private healthcare integration, health systems strengthening, and interventions addressing broader socioeconomic determinants such as poverty, malnutrition, and healthcare inequity. Coordinated multisectoral approaches will be essential for accelerating TB elimination efforts in India in the post-COVID era.<\/jats:p>","DOI":"10.3389\/fepid.2026.1868261","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:21Z","timestamp":1782711561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reimagining tuberculosis elimination in India: diagnostics, drug resistance, and digital health strategies"],"prefix":"10.3389","volume":"6","author":[{"given":"Sneha","family":"Jha","sequence":"first","affiliation":[{"name":"Department of Bioscience, Indrashil University","place":["Rajpur, Gujarat, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loka Bikash","family":"Chaliha","sequence":"additional","affiliation":[{"name":"Department of Bioscience, Indrashil University","place":["Rajpur, Gujarat, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshipra","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Bioscience, Indrashil University","place":["Rajpur, Gujarat, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Bioscience, Indrashil University","place":["Rajpur, Gujarat, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"B2","year":"2024"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(25)02433-X","article-title":"Global tuberculosis response off track: urgent priorities to end the world\u2019s top infectious killer","volume":"407","author":"Hui","year":"2026","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.jctube.2025.100522","article-title":"Strengthening the global response to tuberculosis: insights from the 2024 WHO global TB report","volume":"39","author":"Estaji","year":"2025","journal-title":"J Clin Tuberc Other Mycobacterial Dis"},{"key":"B5","volume-title":"Towards a TB-free India: Achievements, Challenges and the way Forward","year":"2024"},{"key":"B6","year":"2024"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1234785","DOI":"10.3389\/fimmu.2023.1234785","article-title":"The impact of the COVID-19 pandemic on the global tuberculosis epidemic","volume":"14","author":"Falzon","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B9","volume-title":"Tuberculosis Surges Back as top Infectious Disease Killer","year":"2024"},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijmmb.2022.10.008","article-title":"National TB elimination programme\u2014what has changed","volume":"42","author":"Khanna","year":"2023","journal-title":"Indian J Med Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1186\/s12879-019-4169-y","article-title":"Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data","volume":"19","author":"Arinaminpathy","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e080623","DOI":"10.1136\/bmjopen-2023-080623","article-title":"Burden of COVID-19 pandemic on tuberculosis hospitalisation patterns at a tertiary care hospital in Rajasthan, India: a retrospective analysis","volume":"14","author":"Rajotiya","year":"2024","journal-title":"BMJ Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2021022","DOI":"10.4178\/epih.e2021022","article-title":"Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications","volume":"43","author":"Husain","year":"2021","journal-title":"Epidemiol Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/tropicalmed9010012","article-title":"The predicted potential impact of COVID-19 pandemic on tuberculosis epidemic in Tamil Nadu, South India","volume":"9","author":"Muniyandi","year":"2024","journal-title":"Tropical Med Infectious Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.33073\/pjm-2022-018","article-title":"Prevalence and drug resistance pattern of Mycobacterium tuberculosis isolated from tuberculosis patients in Basra, Iraq","volume":"71","author":"Mohammed","year":"2022","journal-title":"Polish J Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1225438","DOI":"10.3389\/fmicb.2023.1225438","article-title":"Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine","volume":"14","author":"Doh\u00e1l","year":"2023","journal-title":"Front Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1128\/aac.04222-14","article-title":"The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules","volume":"59","author":"Danilchanka","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"RP102980","DOI":"10.7554\/eLife.102980.3","article-title":"Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of Mycobacterium tuberculosis","volume":"13","author":"Simwela","year":"2025","journal-title":"eLife"},{"key":"B20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.69656","article-title":"Drug resistance in Mycobacterium tuberculosis","author":"Pe\u00f1uelas-Urquides","year":"2018","journal-title":"Mycobacterium \u2013 Research and Development"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.34172\/ijhpm.2022.6576","article-title":"What makes people with chronic illnesses discontinue treatment? A practice theory informed analysis of adherence to treatment among patients with drug-resistant tuberculosis in Pakistan","volume":"12","author":"Abbas","year":"2023","journal-title":"Int J Health Policy Manag"},{"key":"B23","doi-asserted-by":"publisher","first-page":"790718","DOI":"10.3389\/fmed.2021.790718","article-title":"Frequency and factors associated with adverse events among multi-drug resistant tuberculosis patients in Pakistan: a retrospective study","volume":"8","author":"Atif","year":"2022","journal-title":"Front Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"A119.1","DOI":"10.1136\/thoraxjnl-2013-204457.247","article-title":"P97 multi-drug resistant tuberculosis: the first UK guideline for treatment monitoring","volume":"68","author":"Keal","year":"2013","journal-title":"Thorax"},{"key":"B25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3201\/eid2605.181992","article-title":"Pretreatment out-of-pocket expenses for presumptive multidrug-resistant tuberculosis patients, India, 2016\u20132017","volume":"26","author":"Rathi","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2147\/rmhp.s275400","article-title":"Challenges faced by multidrug-resistant tuberculosis patients in three financially affluent Chinese cities","volume":"13","author":"Zhang","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100285","DOI":"10.1016\/j.jctube.2021.100285","article-title":"The pipeline of new molecules and regimens against drug-resistant tuberculosis","volume":"25","author":"Black","year":"2021","journal-title":"J Clin Tuberc Other Mycobacterial Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0382-3","article-title":"Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia\u2019s implementation of universal health coverage","volume":"7","author":"Fuady","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1007\/s11033-020-05413-7","article-title":"Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis","volume":"47","author":"Acharya","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1183\/13993003.00978-2015","article-title":"Light-emitting diode fluorescence microscopy for tuberculosis diagnosis: a meta-analysis","volume":"47","author":"Chang","year":"2015","journal-title":"Eur Respir J"},{"key":"B31","volume-title":"Fluorescent Light-Emitting Diode (LED) Microscopy for Diagnosis of Tuberculosis: Policy Statement (No. WHO\/HTM\/TB\/2011.8)","year":"2011"},{"key":"B32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/ijmy.ijmy_13_23","article-title":"Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum as proficient alternative tool in the diagnosis of pulmonary tuberculosis in countries with limited resource settings","volume":"12","author":"Coulibaly","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"B33","year":"2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"CD009593","DOI":"10.1002\/14651858.CD009593.pub3","article-title":"Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults","volume":"2014","author":"Steingart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B35","volume-title":"Mycobacteria: Laboratory Methods for Testing Susceptibility to Anti-Tuberculosis Drugs","author":"Canetti","year":"1963"},{"key":"B36","year":"2020"},{"key":"B37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.resinv.2023.04.010","article-title":"Current status and future landscape of diagnosing tuberculosis infection","volume":"61","author":"Kobashi","year":"2023","journal-title":"Respir Investig"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9160","DOI":"10.1038\/s41598-026-40253-8","article-title":"Phenotypic drug resistance and genome sequencing based identified mutations linked to resistance in Mycobacterium tuberculosis isolated from extrapulmonary clinical specimens","volume":"16","author":"Mollalign","year":"2026","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ijtb.2024.08.011","article-title":"Tuberculosis infection prevention and control","volume":"72","author":"Sarkar","year":"2025","journal-title":"Indian J Tuberc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1549044","DOI":"10.3389\/fmicb.2025.1549044","article-title":"Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods","volume":"16","author":"Elbehiry","year":"2025","journal-title":"Front Microbiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1016\/S2214-109X(17)30205-X","article-title":"Cost-effectiveness of Xpert MTB\/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation","volume":"5","author":"Vassall","year":"2017","journal-title":"Lancet Glob Health"},{"key":"B44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijmyco.2014.04.003","article-title":"Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis","volume":"3","author":"Nikam","year":"2014","journal-title":"Int J Mycobacteriol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0327936","DOI":"10.1371\/journal.pone.0327936","article-title":"Diagnostic accuracy of the TrueNat\u2122 MTB plus assay for detecting pulmonary tuberculosis in adults","volume":"20","author":"Mallya","year":"2025","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1183\/09031936.00061808","article-title":"Genotype MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis","volume":"32","author":"Ling","year":"2008","journal-title":"Eur Respir J"},{"key":"B47","year":"2025"},{"key":"B48","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1148\/radiol.2017162326","article-title":"Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks","volume":"284","author":"Lakhani","year":"2017","journal-title":"Radiology"},{"key":"B49","year":"2023"},{"key":"B50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.rppnen.2017.12.002","article-title":"Point of care diagnostics for tuberculosis","volume":"24","author":"Garc\u00eda-Basteiro","year":"2018","journal-title":"Pulmonology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1473-3099(21)00452-7","article-title":"Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: a cross-sectional multicentre diagnostic accuracy study","volume":"22","author":"Penn-Nicholson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B52","year":"2022"},{"key":"B53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1056\/NEJMoa0800106","article-title":"Comprehensive treatment of extensively drug-resistant tuberculosis","volume":"359","author":"Mitnick","year":"2008","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/jama.1995.03530120037038","article-title":"Eleven years of community-based directly observed therapy for tuberculosis","volume":"274","author":"Chaulk","year":"1995","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American thoracic society\/centers for disease control and prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"CD014756","DOI":"10.1002\/14651858.CD014756.pub2","article-title":"Community views on active case finding for tuberculosis in low-and middle-income countries: a qualitative evidence synthesis","volume":"3","author":"Taylor","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"B58","year":"2025"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1056\/NEJMoa2006802","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"383","author":"Sterling","year":"2020","journal-title":"N Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"B61","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"B62","volume-title":"WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment\u2014Drug-Susceptible TB Treatment","year":"2024"},{"key":"B63","volume-title":"WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment\u2014Drug-Resistant TB Treatment","year":"2022"},{"key":"B64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"key":"B66","year":"2020"},{"key":"B67","year":""},{"key":"B68","year":"2020"},{"key":"B69","year":"2017"},{"key":"B70","year":"2023"},{"key":"B71","year":"2023"},{"key":"B72","year":"2023"},{"key":"B73","year":"2022"},{"key":"B74","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s44250-025-00242-6","article-title":"The role of digital health technology in tuberculosis control: a systematic literature review and comparative analysis based on the WHO guidelines","volume":"4","author":"Netto","year":"2025","journal-title":"Discov Health Syst"},{"key":"B75","year":"2020"},{"key":"B76","doi-asserted-by":"publisher","first-page":"100556","DOI":"10.1016\/j.ijregi.2024.100556","article-title":"Advancing tuberculosis elimination in India: a qualitative review of current strategies and areas for improvement in tuberculosis preventive treatment","volume":"14","author":"Shah","year":"2025","journal-title":"IJID Regions"}],"container-title":["Frontiers in Epidemiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2026.1868261\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:23Z","timestamp":1782711563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2026.1868261\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":76,"alternative-id":["10.3389\/fepid.2026.1868261"],"URL":"https:\/\/doi.org\/10.3389\/fepid.2026.1868261","relation":{},"ISSN":["2674-1199"],"issn-type":[{"value":"2674-1199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1868261"}}